Journal profile · Endocrinology & Metabolism
Diabetic Medicine
ISSN 0742-3071 · eISSN 1464-5491 · Wiley-Blackwell Publishing Ltd · ENGLAND · Monthly · Founded 1984
Diabetic Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.24; hybrid open access; APC about USD 4,870; median 122 days to acceptance (99 articles, last 24 months); community-reported acceptance: fairly easy; 247 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diabetic Medicine is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes Management and Education and Diabetes, Cardiovascular Risks, and Lipoproteins, together about 37.2% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Diabetic Medicine, the official journal of Diabetes UK, is published monthly online. The journal publishes a range of key information on all aspects of diabetes mellitus, ranging from basic science investigating cellular mechanisms and pre-clinical models, through clinical physiology and trials to diabetes epidemiology. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed. We aim to disseminate knowledge about diabetes research with the ultimate goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all scientists and healthcare professionals working in diabetes. Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.” Keywords Diabetes; diabetic; diabetes mellitus; diabetology; obesity; metabolism; endocrinology; clinical pharmacology; clinical physiology; experimental pharmacology; lipid metabolism; therapeutics; therapies; diet; dietary; exercise; interventions; metabolic disease; endocrine disease; metabolic syndrome; nutrition; endocrine; preclinical; meta-analyses; drug safety; drug tolerability, islets, beta cells, genetics, immunology, complications, insulin signalling, animal models, transplantation. Abstracting and Indexing Information Abstracts in Anthropology (Sage) Abstracts on Hygiene & Communicable Diseases (CABI) Academic Search (EBSCO Publishing) Academic Search Alumni Edition (EBSCO Publishing) Academic Search Elite (EBSCO Publishing) Academic Search Premier (EBSCO Publishing) Biological Science Database (ProQuest) CAB Abstracts® (CABI) Current Contents: Clinical Medicine (Clarivate Analytics) Dairy Science Abstracts (CABI) Embase (Elsevier) Global Health (CABI) Health & Medical Collection (ProQuest) Health Research Premium Collection (ProQuest) Health Source Nursing/Academic (EBSCO Publishing) HEED: Health Economic Evaluations Database (Wiley-Blackwell) Hospital Premium Collection (ProQuest) Journal Citation Reports/Science Edition (Clarivate Analytics) Leisure Tourism Database (CABI) Leisure, Recreation & Tourism Abstracts (CABI) MEDLINE/PubMed (NLM) Natural Science Collection (ProQuest) Nutrition Abstracts & Reviews Series
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Noel MorganPublisher website
Editorial board by country: 3 in mainland China (about 7%); most named United Kingdom 26, Mainland China 3, India 2, Australia 2, Netherlands 2 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine15.9%
- Diabetes Management and EducationMedicine10.8%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine10.6%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology9.3%
- Diabetes Treatment and ManagementMedicine9.1%
- Pancreatic function and diabetesMedicine5.5%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine5.3%
- Gestational Diabetes Research and ManagementMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.24LetPub ·
- Impact factor (publisher)
- 3.3Publisher website ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- CiteScore 2026-06
- 6.7LetPub ·
- CiteScore (publisher)
- 6.7Publisher website ·
- CiteScore (publisher) 2025
- 6.7Publisher website ·
- SJR 2026-06
- 1.3LetPub ·
- SNIP 2026-06
- 1.21LetPub ·
- h-index
- 132LetPub ·
- h-index
- 210OpenAlex ·
- i10-index
- 6,433OpenAlex ·
- 2-year mean citedness
- 2.62OpenAlex ·
- Self-citation rate
- 6.1%LetPub ·
- Share of gold OA articles
- 59.82%LetPub ·
Volume
- Articles per year
- 184LetPub ·
- Articles per year (publisher) 2025
- 213Publisher website ·
- Downloads per year (publisher) 2025
- 1,097,338Publisher website ·
Articles by year OpenAlex count · 12,509 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 277 | 191 | 91 |
| 2025 | 247 | 192 | 564 |
| 2024 | 236 | 189 | 1,339 |
| 2023 | 253 | 205 | 1,905 |
| 2022 | 259 | 156 | 3,414 |
| 2021 | 376 | 183 | 4,298 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
122 daysMedian, submission to acceptance · P25–P75 76 days – 189 days
- Acceptance to online
- median 20 days (101 articles)
- Submission to online
- median 151 days
- Sample
- 99 articles with submission and acceptance dates (564 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 15%Publisher website ·
- Acceptance rate (publisher) 2025
- 15%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to first decision 2025
- 3 daysPublisher website ·
- Submission to acceptance 2025
- 120 daysPublisher website ·
- Acceptance to publication 2025
- 18 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,870 / EUR 4,060 / GBP 3,240 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,000 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted2, with length limits
- commentarys, unsolicited submissions are welcome. Commentaries should not exceed 1,000 words and 10 references (AMA style, see section 4). No abstractsmain text ≤ 1,000 words
- research paper(AMA style, see section 4). Qualitative research papers may consist of up to 4000 words and 30 references. Papers of less than 3000 words are alsomain text ≤ 4,000 words
Policy excerpts from the journal's websiteAI use
- AI use Artificial Intelligence Generated Content
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship, nor do they have legal standing or the ab…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1984
- ISSN
- 0742-3071
- Electronic ISSN
- 1464-5491
- Society / sponsor
- Diabetes UK
- Latest issue on the website
- Volume 43, Issue 8 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Diabetic Medicine
What CAS zone is Diabetic Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetic Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetic Medicine?
The latest impact factor listed by LetPub is 3.24; CiteScore 6.7, h-index 210.
How long does peer review take at Diabetic Medicine?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 122 days (interquartile range 76–189 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 15% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Diabetic Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,000 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Diabetic Medicine based?
Of the 42 board members whose country the journal's board page names, 3 (about 7%) are in mainland China; the countries named most often are United Kingdom (26), Mainland China (3) and India (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Diabetic Medicine?
According to LetPub and DOAJ records, Diabetic Medicine is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Diabetic Medicine open access, and what is the APC?
Diabetic Medicine is a hybrid journal. For open-access publication: APC about USD 4,870.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .